People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $139.5M | $2.1B | 2013 |
| Affymax Inc | — | Biotechnology | Series C | $42.0M | $1.7B | 2009 |
| Viveve Medical, Inc. | — | Biotechnology | Series A | $41.5M | $12.3M | 2020 |
| Nuon Therapeutics Inc | — | Biotechnology | Series A | $29.7M | $361.5M | 2009 |
| TC BioPharm (Holdings) plc | — | Biotechnology | Series A | $7.3M | $82.8M | 2022 |
Arlene Morris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Arlene Morris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Walker | 1 | 17 |
| Ivor Royston | 1 | 7 |
| Robert More | 1 | 7 |
| Kim Kamdar | 1 | 6 |
| Bob More | 1 | 6 |
| Nicholas Galakatos | 1 | 6 |
| Dennis Podlesak | 1 | 6 |
| Ted W. Love | 1 | 5 |
| Brigitte Smith | 1 | 5 |
| Carl Simpson | 1 | 4 |
| James Atkinson | 1 | 3 |
| Steven Basta | 1 | 3 |
| Daniel Janney | 1 | 3 |
| Keith Leonard | 1 | 3 |
| Joshua Funder | 1 | 3 |
| Rosina Maar Pavia, M.D. | 1 | 2 |
| Kim Kamdar, Ph.D. | 1 | 2 |
| Daniel S Janney | 1 | 2 |
| Tito Serafini | 1 | 2 |
| Mark Colella | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.